Blog Archives

Cancer Moonshot Task Force Report Released

On October 17, the Cancer Moonshot Task Force released a report laying out its implementation plans for accelerating progress in cancer research and care. The plan includes actions launched under the Cancer Moonshot this year as well as  longer-term strategies for the initiative. Established by President Barack Obama, the Task Force consists of 20 federal departments, agencies, and White House offices, with leadership provided by Vice President Joe Biden. The Task Force’s efforts are not intended to supplant existing cancer programs, initiatives, and polices, but to coordinate these efforts in an attempt to quicken the progress associated with them. The report contains five strategic goals: (1) catalyze new scientific breakthroughs, (2) unleash the power of data by “maximizing access to and usability of these data to enhance, improve, and inform,” (3) increase the pace of new therapies, (4) strengthen efforts surrounding prevention and diagnosis, and (5) improve patient access and care. The Task Force notes that the plan is designed to serve as a blueprint for future Administrations (the report was released before last week’s elections). It also includes new commitments made by both the public and private sectors.

Back to this issue’s table of contents.

Tagged with: ,
Posted in Issue 22 (November 15), Update, Volume 35 (2016)

PCORI Announces Commitments in Support for Cancer Moonshot Initiative

The Patient-Centered Outcomes Research Institute (PCORI) has released its plans to support the Vice President’s Cancer Moonshot Initiative.  PCORI’s National Patient-Centered Clinical Research Network (PCORnet) has committed to (1) enhancing its national data network to facilitate large-scale cancer research; (2) creating data tables that describe characteristics of patient cohorts treated for the most common types of cancer; and (3) establishing a Cancer Collaborative Research Group within PCORnet to assist in identifying research questions, developing approaches to integrate big data in cancer prevention and treatment, and reducing disparities. More about PCORI’s support for the Cancer Moonshot is available on its website.

Back to this issue’s table of contents.

Tagged with: , ,
Posted in Issue 14 (July 12), Update, Volume 35 (2016)

White House Announces National Cancer Moonshot Task Force


Photo Credit: The White House

On February 1, the White House announced a new $1 billion initiative to jumpstart the new national “moonshot” initiative announced by President Obama in his 2016 State of the Union Address. The President established the White House Cancer Moonshot Task Force via a presidential memorandum, which will be led by Vice President Biden. The goal of the initiative is “to eliminate cancer as we know it.” The Task Force’s membership will include the leadership of the Departments of Defense (DOD), Commerce (DOC), Health and Human Services (HHS), Energy (DOE), Veterans Affairs (VA), and the Office of Management and Budget, National Economic Council, Domestic Policy Council, Office of Science and Technology Policy, Food and Drug Administration (FDA), National Cancer Institute (NCI), National Institutes of Health (NIH), and the National Science Foundation, among others as designated.  NIH is directed to provide “funding and administrative support” for the Task Force. Additionally, the presidentially-appointed National Cancer Advisory Board (NCAB) is directed to also serve on the Task Force and is “strongly encouraged to establish a working group consisting of a Blue Ribbon Panel of scientific experts.” The Task Force is charged with producing a detailed set of findings and recommendations and delivering a report to the President before December 31, 2016.

The $1 billion initiative will provide research funding to “accelerate the development of new cancer detection and treatments.” It includes $965 million in funding for new cancer activities at the National Institutes of Health (NIH) in fiscal year (FY) 2016. For FY 2017, the President’s budget request will include $755 million in mandatory funds for activities at NIH and FDA. In addition, DOD and VA are directed to increase their investments in cancer research through the funding of “Centers of Excellence focused on specific cancers, and conducting large longitudinal studies to help determine risk factors and enhance treatment.” The initiative’s HHS-supported research areas also include prevention and cancer vaccine development, early cancer detection, cancer immunotherapy and combination therapy, genomic analysis of tumor and surrounding cells, enhanced data sharing, and pediatric cancer. FDA will support an oncology Center of Excellence to “leverage the combined skills of regulatory scientists and reviewers with expertise in drugs, biologics, and devices.”

Back to this issue’s table of contents.

Tagged with: , , , ,
Posted in Issue 3 (February 9), Update, Volume 35 (2016)


Click here to subscribe to the COSSA Washington Update, our biweekly newsletter.


Looking for something from a previous issue of the COSSA Washington Update? Try our archive.


Browse by Month